It has been 30 years since a'new'leukaemia termed adult T-cell leukaemia (ATL) was
described in Japan, and more than 25 years since the isolation of the retrovirus, human T …

Human T-lymphotropic virus 1 (HTLV-1) has infected human beings for thousands of years,
but knowledge about the infection and its pathogenesis is only recently emerging. The virus …

HTLV-1 (Human T-cell lymphotropic virus type 1) is a complex human delta retrovirus that
currently infects 10–20 million people worldwide. While HTLV-1 infection is generally …

The African continent is considered the largest high endemic area for the oncogenic
retrovirus HTLV-1 with an estimated two to five million infected individuals. However, data on …

The clinical entity of adult T-cell leukemia (ATL) was established around 1977, and human T-
cell leukemia virus type 1 (HTLV-I) was subsequently identified in 1980. In the 25 years …

Human T-lymphotropic virus type 1 (HTLV-1) is found in indigenous peoples of the Pacific
Islands and the Americas, whereas type 2 (HTLV-2) is widely distributed among the …

Despite its poorly adapted codon usage, HIV-1 replicates and is expressed extremely well in
human host cells. HIV-1 has recently been shown to package non-lysyl transfer RNAs …

Human T-cell leukemia virus type 1 (HTLV-1) was the first human retrovirus discovered.
Studies on HTLV-1 have been instrumental for our understanding of the molecular …

The first description of the human T-lymphotropic virus type 1 (HTLV-1) was made in 1980,
followed closely by the discovery of HTLV-2, in 1982. Since then, the main characteristics of …

Human T cell leukemia virus (HTLV-1) is an oncoretrovirus that infects at least 10 million
people worldwide. HTLV-1 exhibits a remarkable genetic stability, however, viral strains …